サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790431

在宅輸液療法の市場規模、シェア、動向分析レポート：タイプ別、用途別、地域別、セグメント予測、2025年～2030年

Home Infusion Therapy Market Size, Share & Trends Analysis Report By Type (Product, Services), By Application (Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.30円
在宅輸液療法の市場規模、シェア、動向分析レポート：タイプ別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年07月04日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

在宅輸液療法市場のサマリー

世界の在宅輸液療法市場は、2024年に386億6,000万米ドルと評価され、2025年から2030年にかけてCAGR 8.2%で成長し、2030年には617億2,000万米ドルに達すると予測されています。在宅輸液療法では、治療、投薬、輸液を静脈内輸液によって患者の血流に直接送り込みます。

同市場の成長は、運動能力の低下を特徴とする老年人口の拡大、在宅ケアへの嗜好の高まり、技術進歩の迅速な進化など、いくつかの重要な要因によって牽引されています。輸液療法は、点滴療法や静脈内水分補給療法などの重要なコンポーネントを含み、免疫不全、がん、うっ血性心不全など、経口薬が有効な治療選択肢とならない症状への対応に重要な役割を果たしています。これらの治療に対する需要の高まりは、患者の長期治療の必要性に起因しており、在宅輸液療法は病院での治療に代わる費用対効果の高い治療法として注目されています。点滴療法と静脈内水分補給療法を取り入れることが原動力となり、患者は快適な自宅で効果的かつ個別化された医療ソリューションを利用しやすくなります。

在宅輸液療法の費用対効果の高さは、世界のヘルスケアシステムでの採用を促進する大きな要因となっています。病院外での点滴治療を可能にすることで、入院、再入院、長期滞在など、入院治療に伴う費用が大幅に削減されます。このモデルでは、直接的な治療費が削減され、施設の諸経費やスタッフの人件費といった付随的な支出も最小限に抑えられます。在宅輸液療法は、従来の入院治療と比較して大幅なコスト削減が可能であり、患者やヘルスケア支払者にとって魅力的な選択肢となっています。例えば、全米在宅輸液協会（NHIA）によると、在宅輸液療法のコストは1日当たり約122～225米ドルです。一方、入院治療では、治療内容にもよるが、1日あたり586～798米ドルが必要となります。

麻痺、変形性関節症、糖尿病などの症状により運動能力の低下に悩むベビーブーム世代の人口が増加しているため、在宅輸液療法の需要が拡大すると予想されます。入院期間の短縮が急務となっていることも、市場の成長に大きく寄与する重要な要因です。注目すべきは、アポモルヒネの皮下持続注入療法がパーキンソン病（PD）に対する極めて有効な治療法であることで、皮下デリバリーによるPDの管理には多様な製剤が利用可能です。PDの負担増に対応するため、皮下輸液療法に対する需要が顕著に急増しています。例えば、Parkinson's Foundationの2022年のデータ更新によると、米国では毎年約9万人がPDの診断を受けています。さらに、米国では2030年までにPD患者数が120万人近くに急増すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 在宅輸液療法市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 在宅輸液療法市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 在宅輸液療法市場：タイプ別の推定・動向分析

  • タイプ別のセグメントダッシュボード
  • 在宅輸液療法市場の変動分析：タイプ別
  • 世界の在宅輸液療法市場規模と動向分析：タイプ別、2018年～2030年
  • 製品
    • 輸液ポンプ
    • エラストマー
    • 電気機械
    • 重力
    • その他
    • 静脈内セット
    • IVカニューラ
    • ニードルレスコネクタ
  • サービス

第5章 在宅輸液療法市場：用途別の推定・動向分析

  • 用途別のセグメントダッシュボード
  • 在宅輸液療法市場の変動分析：用途別
  • 世界の在宅輸液療法市場規模と動向分析：用途別、2018年～2030年
  • 抗感染
  • 内分泌学
    • 糖尿病
    • その他
  • 水分補給療法
    • アスリート
    • その他
  • 化学療法
  • 経腸栄養
  • 経腸栄養
  • 専門医薬品
  • その他

第6章 在宅輸液療法市場：地域別の推定・動向分析

  • 地域別の市場ダッシュボード
  • 地域別の市場シェア分析、2024年および2030年
  • 地域別の連続バイオプロセス市場：主なポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • ベルギー
    • スイス
    • ロシア
    • スウェーデン
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • マレーシア
    • シンガポール
    • タイ
    • フィリピン
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • コロンビア
    • チリ
  • 中東およびアフリカ（MEA）
    • アルゼンチン
    • 南アフリカ
    • 南アラビア
    • アラブ首長国連邦
    • イスラエル
    • エジプト

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業ヒートマップ分析、2024年
  • 企業プロファイル
    • Baxter
    • B. Braun SE
    • BD
    • Fresenius Kabi AG
    • ICU Medical, Inc.
    • Terumo Corporation
    • JMS Co. Ltd.
    • Option Care Health, Inc.
    • CareCentrix, Inc.
    • Coram LLC.
    • PharMerica Corporation
    • Moog Inc.
    • Amedisys, Inc.
図表

List of Tables

  • Table 1 : List of abbreviations
  • Table 2 Home infusion therapy market (USD Million), 2018 - 2030
  • Table 3 Global home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global home infusion therapy market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America home infusion therapy market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 10 U.S. home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 13 Mexico home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe home infusion therapy market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 17 Europe home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 18 UK home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 19 UK home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 20 Germany home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 22 France home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 23 France home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 24 Spain home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 25 Spain home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 26 Italy home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 27 Italy home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 28 Netherlands home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 29 Netherlands home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 30 Belgium home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 31 Belgium home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 32 Switzerland home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 33 Switzerland home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 34 Russia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 35 Russia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 37 Sweden home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific home infusion therapy market, by country, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 41 Japan home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 42 Japan home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 43 China home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 44 China home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 45 India home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 46 India home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 47 Australia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 48 Australia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 49 South Korea home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 50 South Korea home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 51 Indonesia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 52 Indonesia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 53 Malaysia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 54 Malaysia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 55 Singapore home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 56 Singapore home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 57 Thailand home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 58 Thailand home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 59 Philippines home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 60 Philippines home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 61 Latin America home infusion therapy market, by country, 2018 - 2030 (USD Million)
  • Table 62 Latin America home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 64 Brazil home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 65 Brazil home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 66 Argentina home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 67 Argentina home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 68 Colombia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 69 Colombia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 70 Chile home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 71 Chile home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa home infusion therapy market, by country, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 75 South Africa home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 76 South Africa home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 77 South Arabia home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 78 South Arabia home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 79 UAE home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 80 UAE home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 81 Israel home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 82 Israel home infusion therapy market, by application, 2018 - 2030 (USD Million)
  • Table 83 Egypt home infusion therapy market, by type, 2018 - 2030 (USD Million)
  • Table 84 Egypt home infusion therapy market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Home infusion therapy market: Market outlook
  • Fig. 10 Home infusion therapy competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Home infusion therapy market driver impact
  • Fig. 16 Home infusion therapy market restraint impact
  • Fig. 17 Home infusion therapy market strategic initiatives analysis
  • Fig. 18 Home infusion therapy market: Type movement analysis
  • Fig. 19 Home infusion therapy market: Type outlook and key takeaways
  • Fig. 20 Product market estimates and forecast, 2018 - 2030
  • Fig. 21 Infusion Pumps market estimates and forecast, 2018 - 2030
  • Fig. 22 Elastomeric market estimates and forecast, 2018 - 2030
  • Fig. 23 Electromechanical market estimates and forecast, 2018 - 2030
  • Fig. 24 Gravity market estimates and forecast, 2018 - 2030
  • Fig. 25 Other market estimates and forecast, 2018 - 2030
  • Fig. 26 Intravenous Sets market estimates and forecast, 2018 - 2030
  • Fig. 27 IV Cannulas market estimates and forecast, 2018 - 2030
  • Fig. 28 Needleless Connectors market estimates and forecast, 2018 - 2030
  • Fig. 29 Services market estimates and forecast, 2018 - 2030
  • Fig. 30 Home infusion therapy market: Application movement analysis
  • Fig. 31 Home infusion therapy market: Application outlook and key takeaways
  • Fig. 32 Anti-Infective market estimates and forecasts, 2018 - 2030
  • Fig. 33 Endocrinology market estimates and forecasts, 2018 - 2030
  • Fig. 34 Diabetes market estimates and forecasts, 2018 - 2030
  • Fig. 35 Other market estimates and forecasts, 2018 - 2030
  • Fig. 36 Hydration Therapy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Athlete market estimates and forecasts, 2018 - 2030
  • Fig. 38 Other market estimates and forecasts, 2018 - 2030
  • Fig. 39 Chemotherapy market estimates and forecasts, 2018 - 2030
  • Fig. 40 Enteral Nutrition market estimates and forecasts, 2018 - 2030
  • Fig. 41 Parenteral Nutrition market estimates and forecasts, 2018 - 2030
  • Fig. 42 Speciality Pharmaceuticals market estimates and forecasts, 2018 - 2030
  • Fig. 43 Other market estimates and forecasts, 2018 - 2030
  • Fig. 44 Global home infusion therapy market: Regional movement analysis
  • Fig. 45 Global home infusion therapy market: Regional outlook and key takeaways
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 51 UK market estimates and forecasts, 2018 - 2030
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 53 France market estimates and forecasts, 2018 - 2030
  • Fig. 54 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 55 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 56 Netherlands market estimates and forecasts, 2018 - 2030
  • Fig. 57 Belgium market estimates and forecasts, 2018 - 2030
  • Fig. 58 Switzerland market estimates and forecasts, 2018 - 2030
  • Fig. 59 Russia market estimates and forecasts, 2018 - 2030
  • Fig. 60 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 62 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 63 China market estimates and forecasts, 2018 - 2030
  • Fig. 64 India market estimates and forecasts, 2018 - 2030
  • Fig. 65 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 67 Indonesia market estimates and forecasts, 2018 - 2030
  • Fig. 68 Malaysia market estimates and forecasts, 2018 - 2030
  • Fig. 69 Singapore market estimates and forecasts, 2018 - 2030
  • Fig. 70 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 71 Philippines market estimates and forecasts, 2018 - 2030
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 73 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 74 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 75 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 76 Chile market estimates and forecasts, 2018 - 2030
  • Fig. 77 Middle East & Africa (MEA) market estimates and forecasts, 2018 - 2030
  • Fig. 78 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 79 South Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 80 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 81 Israel market estimates and forecasts, 2018 - 2030
  • Fig. 82 Egypt market estimates and forecasts, 2018 - 2030
目次
Product Code: 978-1-68038-389-8

Home Infusion Therapy Market Summary

The global home infusion therapy market was valued at USD 38.66 billion in 2024 and is expected to reach USD 61.72 billion by 2030, growing at a CAGR of 8.2% from 2025 to 2030. Home infusion therapy involves delivering treatments, medications, or fluids directly into a patient's bloodstream through intravenous (IV) infusion, usually in the comfort and convenience of their home.

The market's growth is driven by several key factors, including the expanding geriatric population characterized by decreased mobility, a rising preference for home care, and the swift evolution of technological advancements. Infusion therapy, encompassing essential components like IV therapy and IV hydration therapy, plays a crucial role in addressing conditions such as immune deficiencies, cancer, and congestive heart failure, where oral medication is not a viable treatment option. The increasing demand for these therapies stems from the need for long-term treatment among patients, positioning home infusion therapy as a notably cost-effective alternative to hospital-based care. Incorporating IV therapy and IV hydration therapy serves as a driving force, providing patients with enhanced accessibility to effective and personalized medical solutions in the comfort of their homes.

The cost-effectiveness of home infusion therapy is a major factor driving its adoption across global healthcare systems. Enabling IV treatments outside hospital settings significantly reduces expenses associated with inpatient care, including hospital admissions, re-admissions, and extended stays. This model lowers direct treatment costs and minimizes ancillary expenditures such as facility overhead and staffing. Home infusion therapy offers substantial cost savings compared to traditional inpatient care, making it an attractive option for patients and healthcare payers. For instance,according to the National Home Infusion Association (NHIA), home infusion therapy costs approximately USD 122 to USD 225 per day. In contrast, inpatient care can range from USD 586 to USD 798 per day, depending on the therapy administered.

The increasing demographic of baby boomers struggling with diminished mobility due to conditions such as paralysis, osteoarthritis, and diabetes is expected to amplify the demand for home infusion therapy. The growing imperative to reduce the duration of inpatient stays is a pivotal factor poised to contribute significantly to the market's growth. Remarkably, continuous subcutaneous (SC) apomorphine infusion emerges as an exceptionally effective treatment for Parkinson's disease (PD), with diverse drug formulations available for the management of PD through subcutaneous delivery. In response to the mounting burden of PD, there is a notable surge in the demand for subcutaneous infusion therapy. For instance, in line with the Parkinson's Foundation's 2022 data update, approximately 90,000 individuals receive a PD diagnosis annually in the U.S. Furthermore, the anticipated number of people living with PD in the country is projected to soar to nearly 1.2 million by the year 2030.

Global Home Infusion Therapy Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels as well as provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the home infusion therapy market report on the basis of type, application, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Product
    • Infusion Pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
    • Intravenous Sets
    • IV Cannulas
    • Needleless Connectors
  • Services
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Anti-Infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athlete
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Russia
    • Sweden
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Singapore
    • Thailand
    • Philippines
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Egypt
    • Rest of Middle East & Africa (MEA)

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Home Infusion Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Home Infusion Therapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Home Infusion Therapy Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Home Infusion Therapy Market: Type Movement Analysis
  • 4.3. Global Home Infusion Therapy Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
  • 4.4. Product
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Infusion Pumps
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Elastomeric
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Electromechanical
        • 4.4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Gravity
        • 4.4.5.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Others
        • 4.4.6.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Intravenous Sets
      • 4.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.8. IV Cannulas
      • 4.4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.9. Needleless Connectors
  • 4.5. Services
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Home Infusion Therapy Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Home Infusion Therapy Market: Application Movement Analysis
  • 5.3. Global Home Infusion Therapy Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Anti-Infective
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Endocrinology
    • 5.5.1. Diabetes
      • 5.5.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Others
      • 5.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Hydration Therapy
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Athlete
      • 5.6.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.3. Others
      • 5.6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Chemotherapy
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Enteral Nutrition
    • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.9. Parenteral Nutrition
    • 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.10. Specialty Pharmaceuticals
    • 5.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Home Infusion Therapy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Continuous Bioprocessing Market By Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.1.3. Competitive Scenario
      • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.1.3. Competitive Scenario
      • 6.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Netherlands
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Netherlands Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Belgium
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Belgium Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Switzerland
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.8.3. Competitive Scenario
      • 6.5.8.4. Switzerland Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.9. Russia
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.9.3. Competitive Scenario
      • 6.5.9.4. Russia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.10. Sweden
      • 6.5.10.1. Key Country Dynamics
      • 6.5.10.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.10.3. Competitive Scenario
      • 6.5.10.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.1.3. Competitive Scenario
      • 6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.4. South Korea
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Indonesia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Indonesia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Malaysia
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.7.3. Competitive Scenario
      • 6.6.7.4. Malaysia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Singapore
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.8.3. Competitive Scenario
      • 6.6.8.4. Singapore Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.9. Thailand
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.9.3. Competitive Scenario
      • 6.6.9.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.10. Philippines
      • 6.6.10.1. Key Country Dynamics
      • 6.6.10.2. Regulatory Framework/ Reimbursement Structure
      • 6.6.10.3. Competitive Scenario
      • 6.6.10.4. Philippines Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.1.3. Competitive Scenario
      • 6.7.1.4. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. Colombia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.5. Chile
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.7.5.3. Competitive Scenario
      • 6.7.5.4. Chile Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8. Middle East & Africa (MEA)
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.1.3. Competitive Scenario
      • 6.8.1.4. Middle East & Africa (MEA)Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.3. South Africa
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.3.3. Competitive Scenario
      • 6.8.3.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.4. South Arabia
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.4.3. Competitive Scenario
      • 6.8.4.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.5. UAE
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.5.3. Competitive Scenario
      • 6.8.5.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.6. Israel
      • 6.8.6.1. Key Country Dynamics
      • 6.8.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.6.3. Competitive Scenario
      • 6.8.6.4. Israel Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.8.7. Egypt
      • 6.8.7.1. Key Country Dynamics
      • 6.8.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.8.7.3. Competitive Scenario
      • 6.8.7.4. Egypt Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key Company Heat Map Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Baxter
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Type Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. B. Braun SE
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Type Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. BD
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Type Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Fresenius Kabi AG
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Type Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. ICU Medical, Inc.
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Type Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Terumo Corporation
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Type Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. JMS Co. Ltd.
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Type Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Option Care Health, Inc.
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Type Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. CareCentrix, Inc.
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Type Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Coram LLC.
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Type Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. PharMerica Corporation
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Type Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. Moog Inc.
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Type Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. Amedisys, Inc.
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Type Benchmarking
      • 7.4.13.4. Strategic Initiatives